Lauri Ahvenjärvi
Oulu University Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lauri Ahvenjärvi.
Cytotherapy | 2015
Tuomas Mäkelä; Reijo Takalo; Oiva Arvola; Henri Haapanen; Fredrik Yannopoulos; Roberto T. Blanco; Lauri Ahvenjärvi; Kai Kiviluoma; Erja Kerkelä; Johanna Nystedt; Tatu Juvonen; Petri Lehenkari
BACKGROUND AIMS Bone marrow mononuclear cells (BM-MNCs) and bone marrow-derived mesenchymal stem stromal cells (BM-MSCs) could have therapeutic potential for numerous conditions, including ischemia-related injury. Cells transplanted intravascularly may become entrapped in the lungs, which potentially decreases their therapeutic effect and increases the risk for embolism. METHODS Twelve pigs were divided into groups of 3 and received (99m)Tc- hydroxymethyl-propylene-amine-oxime-labeled autologous BM-MNCs or allogeneic BM-MSCs by either intravenous (IV) or intra-arterial (IA) transplantation. A whole body scan and single photon emission computed tomography/computed tomography (SPECT/CT) were performed 8 h later, and tissue biopsies were collected for gamma counting. A helical CT scan was also performed on 4 pigs to detect possible pulmonary embolism, 2 after IV BM-MSC injection and 2 after saline injection. RESULTS The transplantation route had a greater impact on the biodistribution of the BM-MSCs than the BM-MNCs. The BM-MNCs accumulated in the spleen and bones, irrespective of the administration route. The BM-MSCs had relatively higher uptake in the kidneys. The IA transplantation decreased the deposition of BM-MSCs in the lungs and increased uptake in other organs, especially in the liver. Lung atelectases were frequent due to mechanical ventilation and attracted transplanted cells. CT did not reveal any pulmonary embolism. CONCLUSIONS Both administration routes were found to be safe, but iatrogenic atelectasis might be an issue when cells accumulate in the lungs. The IA administration is effective in avoiding pulmonary entrapment of BM-MSCs. The cell type and administration method both have a major impact on the acute homing.
Journal of Trauma-injury Infection and Critical Care | 2011
Lauri Ahvenjärvi; Vesa Koivukangas; Airi Jartti; Pasi Ohtonen; Juha Saarnio; Hannu Syrjälä; Jouko Laurila; Tero Ala-Kokko
BACKGROUND Acute acalculous cholecystitis (AAC) is a potentially fatal condition mainly affecting critically ill patients. Current experience from computed tomography (CT) findings in AAC is contradictory. METHODS CT images of 127 mixed medical-surgical intensive care unit patients were retrospectively reviewed for the following findings: bile density, thickness and enhancement of the gallbladder (GB) wall, subserosal edema, greatest perpendicular diameters of the GB, width of extrahepatic bile ducts, gas within the GB, ascites, peritoneal fat edema, and diffuse tissue edema. Forty-three of these patients underwent open cholecystectomy, and 8 patients revealed a normal GB, 26 an edematous GB, and 9 a necrotic AAC. RESULTS Abnormal CT findings were present in 96% of all the intensive care unit patients. Higher bile density in the GB body and subserosal edema was associated with an edematous GB (specificity, 93.6%; sensitivity, 23.1%). The most specific findings predicting necrotic AAC were gas in the GB wall or lumen, lack of GB wall enhancement, and edema around the GB (specificity, 99.2%, 94.9%, and 92.4%, respectively; and sensitivity, 11.1%, 37.5%, and 22.2%, respectively). CONCLUSIONS The frequency of nonspecific abnormal findings in the GB of critically ill patients limits the diagnostic value of CT scanning in detecting AAC. However, in the case of totally normal GB findings in CT, the probability of necrotic AAC is low.
Neurocritical Care | 2012
Petri Kuusinen; Tero Ala-Kokko; Airi Jartti; Lauri Ahvenjärvi; Pirjo Saynajakangas; Pasi Ohtonen; Hannu Syrjälä
BackgroundDiagnosis of pneumonia in the hospital setting is a challenge due to the absence of a generally accepted pneumonia definition.MethodsWe prospectively evaluated six different clinical criteria for diagnosing pneumonia—physician’s diagnosis (A), was compared to common methods, i.e., general surveillance method (B), consensus clinical criteria (C), and other three criteria (D, E, and F) among 390 neurosurgical patients treated in either the intensive care unit or the neurosurgical ward in a university hospital.ResultsThe frequencies of pneumonia cases were: group A, 66 (16.9%); group B, 41 (10.1%); and group C, 55 (14.1%). Only 28 pneumonia cases were identified by all three criteria. The kappa values were: between A and B, 0.42 (95% confidence interval, CI; 0.27–0.57); between A and C, 0.49 (95% CI; 0.35–0.63); and between B and C, 0.68 (95% CI; 0.55–0.80). In group A, there were 34 false positive cases according to criterion B and 25 according to criterion C. Pneumonia cases were identified according to criterion D in 13 (3.3%), E in 35 (9.0%), and F in 51 (13.1%) cases, respectively.ConclusionsThere was great variability in the presence of pneumonia among neurosurgical patients, depending on the criteria used. Our results support the idea that a more exact method for pneumonia diagnosis should be implemented to obtain more reliable results in this important infection of hospitalized patients, which is also used for benchmarking purposes. Furthermore, it seems important to treat all clinically suspected pneumonia cases whether or not the surveillance criteria are fulfilled.
Acta Anaesthesiologica Scandinavica | 2008
Lauri Ahvenjärvi; J. Laurila; Airi Jartti; Pekka Ylipalosaari; Tero Ala-Kokko; Hannu Syrjälä
Background: There is a lack of studies showing the overall impact of multi‐detector computed tomography (MDCT) on the treatment of critically ill patients in a general intensive care unit (ICU) setting.
Acta Anaesthesiologica Scandinavica | 2016
J. Karhu; Tero Ala-Kokko; Lauri Ahvenjärvi; E. Rauvala; Pasi Ohtonen; Hannu Syrjälä
The value of early chest computed tomography (CT) was evaluated among severe community‐acquired pneumonia (SCAP) patients.
Cytotherapy | 2010
Jonne Tikkanen; Hannu-Ville Leskelä; Siri Lehtonen; Vesa Vähäsarja; Jukka Melkko; Lauri Ahvenjärvi; Eija Pääkkö; Kalervo Väänänen; Petri Lehenkari
BACKGROUND AIMS Congenital pseudarthrosis of the tibia (CPT) caused by neurofibromatosis type 1 (NF1) is a refractory disease occurring in childhood. We present two cases that had failed all earlier treatment attempts and, as a last treatment attempt, the patients were chosen to receive mesenchymal stromal cell (MSC) transplantation prior to amputation. METHODS The MSC from bone marrow (BM) were harvested from the iliac crest and cultured in osteoinductive medium for 3 weeks. The cultured MSC were injected in solution into BM canals of the tibia and around the resection line or bone defect in a 3-dimensional collagen sponge scaffold. After the MSC transplantation, the patients were monitored during a 10-month follow-up period. In both cases, bone formation at the pseudarthrosis site was observed and two of three treated bone defects healed. For clinical reasons not related to cell transplantation, such as new infection and pseudarthrosis and severe shortening of the leg, both extremities were finally amputated and bone samples were analyzed to evaluate MSC therapy effect and safety. RESULTS MSC transplantation normalized bone remodeling, promoted bone resorption and improved the overall structure of bone. The number of osteoclasts in the cortical bone was 2-fold higher compared with the monitored situation before MSC transfer. In addition, the mineral content of the bone improved after transplantation. We could see no sign of aberrant bone formation or malignant transformation. CONCLUSIONS Our data suggest that MSC transplantation is a possibility for treatment of CPT caused by NF1 in less severe cases without adjunct defects.
The Annals of Thoracic Surgery | 2007
Fausto Biancari; Jarmo Lahtinen; Risto Ojala; Lauri Ahvenjärvi; Airi Jartti; Martti Mosorin; Jouni Heikkinen; Panu Taskinen; Martti Lepojärvi
American Journal of Surgery | 2006
Jarmo Lahtinen; Lauri Ahvenjärvi; Fausto Biancari; Risto Ojala; Martti Mosorin; Riccardo Cresti; Martti Lepojärvi; Tatu Juvonen
European Radiology | 2016
Esa Liukkonen; Airi Jartti; Marianne Haapea; Heljä Oikarinen; Lauri Ahvenjärvi; Seija Mattila; Terhi Nevala; Kari Palosaari; Marja Perhomaa; Miika T. Nieminen
BMC Infectious Diseases | 2017
Pekka Ylipalosaari; Tero Ala-Kokko; Jouko Laurila; Lauri Ahvenjärvi; Hannu Syrjälä